MYRIAD GENETICS INC (CIK: 0000899923) EDGAR, Information, Filings... CompaniesBIO.Com

MYRIAD GENETICS INC

Mailing address
320 WAKARA WAY, SALT LAKE CITY, Delaware, 84108
Phone
801-584-3600
State location
Utah
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Filings
N/A

MYRIAD GENETICS INC (CIK: 0000899923) is an American company incorporated in the state of Utah. Head office is located at 320 WAKARA WAY, SALT LAKE CITY, Utah, 84108. Work in the industry 2835 - (CF Office: Office of Life Sciences) IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES. MYRIAD GENETICS INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Dreismann Heinrich	0001379372	Jun-01-2023	director
Ancona Margaret	0001843568	Mar-15-2023	officer: SVP, Chief of Staff
Wong Pamela	0001885862	Mar-15-2023	officer: Chief Legal Officer
Solaiman Shereen	0001472827	Mar-01-2023	officer: Chief People Officer
BISARO PAUL	0001237253	Oct-31-2022	director
Haas Kevin Richard	0001843872	Sep-25-2022	officer: Chief Technology Officer
Muzzey Dale	0001922964	Sep-25-2022	officer: Chief Scientific Officer
Lambert Nicole	0001770252	Aug-25-2022	officer: Chief Operating Officer
Munk Natalie	0001932320	Aug-25-2022	officer: Chief Accounting Officer
Newcomer Lee Nisley	0001788981	Jun-02-2022	director
Kumar Rashmi	0001824720	Jun-02-2022	director
Phanstiel S. Louise	0001471518	Jun-03-2021	director
Parkinson Paul	0001826133	May-14-2021	officer: Fmr EVP Strategy & Innovation
Jackson Benjamin	0001779964	Apr-12-2021	officer: Former E.V.P., General Counsel
Santa Eric	0001853654	Apr-01-2021	officer: Chief Growth Officer
Hart Jayne B.	0001519749	Sep-24-2020	officer: Executive VP Human Resources
DIAZ PAUL J	0001194247	Aug-13-2020	director, officer: President and CEO
Skovronsky Daniel	0001741474	Jul-21-2020	director
SPIEGELMAN DANIEL K	0001238403	May-27-2020	director
King Gary A.	0001495800	Sep-30-2019	officer: Exec. VP International Ops
Reitan Colleen F	0001740730	Sep-25-2019	director
Sanders Walter Lloyd	0001349943	Aug-01-2018	officer: President Myriad Oncology
Capone Mark Christopher	0001352413	May-30-2018	officer: President & C.E.O.
Verratti Mark	0001517026	Aug-01-2017	officer: President Assurex Health Inc.
Drosos Virginia	0001554969	Sep-01-2016	officer: President Assurex Health
Ford Alexander	0001644335	Jul-01-2015	officer: President, MGL
Wenstrup Richard	0001645683	Jul-01-2015	officer: Chief Medical Officer
Tobin Bernard	0001628656	Jan-02-2015	officer: President Crescendo BioScience
Riggsbee Richard Bryan	0001621899	Oct-16-2014	officer: Chief Financial Officer
HAGSTROM WILLIAM A	0001042875	Feb-28-2014	officer: Pres. Crescendo Bioscience
McDade Ralph L	0001594674	Jan-01-2014	officer: President Myriad RBM, Inc.
Rogers Ronald S.	0001573382	Apr-01-2013	officer: Exec VP Corp Communications
DREISMANN HEINRICH	0001471714	Dec-02-2011	director
BENSON T CRAIG	0001078422	Jun-01-2011	officer: President, Myriad RBM
BEST LAWRENCE C	0001191248	Sep-16-2009	director
Harrison Robert Gardner	0001421563	Jan-01-2008	officer: Chief Information Officer
Belle Gerald P.	0001416041	Nov-15-2007	director
Evans James S	0001352414	Feb-06-2007	officer: Vice President Finance
HAYES ARTHUR HULL JR	0001267713	Nov-11-2004	director
Laslie W Wayne	0001305949	Oct-11-2004	officer: Chief Operating Officer, MPI
HENDERSON JOHN T	0001226488	May-01-2004	director
LANGER DENNIS	0001274225	May-01-2004	director
ATTIYEH ROBERT S	0001271097	Dec-01-2003	director
STRINGFELLOW DALE A	0001191073	Nov-12-2003	director
HAYES ARTHUR H JR	0001191077	Nov-12-2003	director
GILBERT WALTER PHD	0001236368	Nov-12-2003	director
WILSON LINDA S	0001191072	Nov-05-2003	director
MARSH RICHARD M	0001206386	Sep-09-2003	officer: V.P., General Counsel
LANCHBURY JERRY S	0001219036	Sep-09-2003	officer: Senior V.P. - Research
MELDRUM PETER D	0001008310	Feb-13-2003	director, officer: President
SKOLNICK MARK H	0001008315	Feb-13-2003	director, officer: Chief Scientific Officer
MOYES JAY M	0001191062	Feb-13-2003	officer: Chief Financial Officer
SIMON S GEORGE	0001191074	Feb-13-2003	officer: Vice President
HOCKETT WILLIAM A III	0001191075	Feb-13-2003	officer: Vice President
HOBDEN ADRIAN N	0001191076	Feb-13-2003	officer: President
CRITCHFIELD GREGORY C	0001191080	Feb-13-2003	officer: President

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by MYRIAD GENETICS INC

Filings	Format	Description	Filed/Effective	File/Film Number
SCHEDULE 13G/A	Document	Acc-no: 0000902219-25-000066 (34 Act) Size: KB	Feb-10-2025	005-48577 25604143
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001832406-25-000002 ( Act) Size: 0 KB	Jan-30-2025
8-K	Document	Current report filing Acc-no: 0000899923-25-000002 (34 Act) Size: KB	Jan-15-2025	000-26642 25531252
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001922964-25-000002 ( Act) Size: 0 KB	Jan-02-2025
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001738340-24-000004 ( Act) Size: 0 KB	Dec-12-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-050787 ( Act) Size: 0 KB	Dec-11-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001628280-24-050627 ( Act) Size: 0 KB	Dec-10-2024
8-K	Document	Current report filing Acc-no: 0000899923-24-000065 (34 Act) Size: KB	Dec-10-2024	000-26642 241538549
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001738340-24-000002 ( Act) Size: 0 KB	Dec-02-2024
8-K	Document	Current report filing Acc-no: 0000899923-24-000060 (34 Act) Size: KB	Nov-26-2024	000-26642 241504677
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000905148-24-003139 (34 Act) Size: KB	Nov-14-2024	005-48577 241462601
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000899923-24-000057 (34 Act) Size: KB	Nov-08-2024	000-26642 241438078
8-K	Document	Current report filing Acc-no: 0000899923-24-000054 (34 Act) Size: KB	Nov-07-2024	000-26642 241435791
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-042750 ( Act) Size: 0 KB	Oct-11-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001959173-24-006967 (33 Act) Size: 0 KB	Oct-11-2024	000-26642 241366671
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001517026-24-000006 ( Act) Size: 0 KB	Oct-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001922964-24-000008 ( Act) Size: 0 KB	Oct-10-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001843872-24-000004 ( Act) Size: 0 KB	Oct-10-2024
8-K	Document	Current report filing Acc-no: 0000899923-24-000048 (34 Act) Size: KB	Oct-09-2024	000-26642 241361421
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001517026-24-000004 ( Act) Size: 0 KB	Sep-23-2024

Recent 20 filings. View all MYRIAD GENETICS INC filings

Overall rating 5.0

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

MYRIAD GENETICS INC overview
MYRIAD GENETICS INC job
MYRIAD GENETICS INC stock
MYRIAD GENETICS INC ownership
MYRIAD GENETICS INC CEO
MYRIAD GENETICS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.